1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Subcutaneous Immunoglobulin (SCIg) Market
2.3. Global Subcutaneous Immunoglobulin (SCIg) Market, By Application, 2025 (US$ Million)
2.4. Global Subcutaneous Immunoglobulin (SCIg) Market, By End-users, 2025 (US$ Million)
2.5. Global Subcutaneous Immunoglobulin (SCIg) Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Subcutaneous Immunoglobulin (SCIg) Market: Competitive Analysis
3.1. Market Positioning of Key Subcutaneous Immunoglobulin (SCIg) Market Vendors
3.2. Strategies Adopted by Subcutaneous Immunoglobulin (SCIg) Market Vendors
4. Subcutaneous Immunoglobulin (SCIg) Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Subcutaneous Immunoglobulin (SCIg) Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Primary Immunodeficiency Diseases
5.3.2. Secondary Immunodeficiency Diseases
5.3.3. Others (Neurological Disorders, Infectious Diseases, Bleeding Disorders etc.)
6. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Homecare
6.3.3. Clinics
7. North America Subcutaneous Immunoglobulin (SCIg) Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
7.3. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
7.4. Subcutaneous Immunoglobulin (SCIg) Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
7.4.1.1.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
7.4.1.2.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
7.4.1.3.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8. UK and European Union Subcutaneous Immunoglobulin (SCIg) Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.3. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4. Subcutaneous Immunoglobulin (SCIg) Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.1.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.2.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.3.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.4.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.5.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
8.4.1.6.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9. Asia Pacific Subcutaneous Immunoglobulin (SCIg) Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.3. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4. Subcutaneous Immunoglobulin (SCIg) Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.1.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.2.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.3.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.4.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.5.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
9.4.1.6.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
10. Latin America Subcutaneous Immunoglobulin (SCIg) Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
10.3. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
10.4. Subcutaneous Immunoglobulin (SCIg) Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
10.4.1.1.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
10.4.1.2.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
10.4.1.3.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
11. Middle East and Africa Subcutaneous Immunoglobulin (SCIg) Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
11.3. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
11.4. Subcutaneous Immunoglobulin (SCIg) Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
11.4.1.1.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
11.4.1.2.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Subcutaneous Immunoglobulin (SCIg) Market: By Application, 2024-2034, USD (Million)
11.4.1.3.2. Subcutaneous Immunoglobulin (SCIg) Market: By End-users, 2024-2034, USD (Million)
12. Company Profile
12.1. Baxalta Incorporated (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Biotest AG
12.3. CSL Behring, LLC
12.4. Grifols S.A.
12.5. Kedrion S.p.A.
12.6. Octapharma AG
12.7. Shire Plc
12.8. Talecris Biotherapeutics, Inc.
12.9. Others
